Big pharma, big data: why drugmakers want your health records

March, 1, Reuters: This feature is of interest to anyone in the smart packaging and data analytics space about data, privacy and the drive to use more “real-world evidence,” or RWE. Regulators believe this could cut the drug development costs associated with traditional clinical trial research, and help health-care professionals make better medical choices.

Read the full article.